TotalMarketCap

Cellectar Biosciences

CLRBNasdaq United StatesHealth CareBiotechnology: Pharmaceutical Preparations

Market cap

$10.964 M

$1.16 -5.69%

Close of 6 Nov 2026

As of 6 Nov 2026, Cellectar Biosciences (CLRB) has a market capitalization of $11.0M. Market cap measures the value of outstanding equity at market prices; company totals combine applicable share classes. Prices and market caps come from Nasdaq, with financial fundamentals from SEC filings. See sources and calculation details.

Revenue

—

Not reported

Earnings

-$21.8M

Loss-making

Shares outstanding

9,452,108

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: Pharmaceutical Preparations, ranked by market cap

All 498 →
  1. #407AEON BiopharmaAEON$11.3M
  2. #408VyomeHIND$11.3M
  3. #409Cellectar BiosciencesCLRB$11.0M
  4. #410Lisata TherapeuticsLSTA$10.8M
  5. #411Palatin TechnologiesPTN$10.5M

What if Cellectar Biosciences were worth as much as…

Open the what-if tool →

Gold $28.2T

$2,987,363

Per share 2,575,313× higher

Bitcoin $1.53T

$161,640.99

Per share 139,346× higher

Apple $5.02T

$530,652.29

Per share 457,459× higher

Or at a round number

$20.0M$50.0M$100.0M$200.0M

Where these numbers come from

Share counts and financials for Cellectar Biosciences are taken from its own SEC filings via EDGAR: public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Read the methodology.